Evidence map›Paper›PMID 42680762›Full record

ArticleNature communications2026

Long-read proteogenomic atlas of human neuronal differentiation reveals isoform diversity informing neurodevelopmental risk mechanisms.

Nuo Xu, Katherine M Rynard, Elizabeth Radley, Ai Tian, Maahil Arshad, Chaoying Long, Jimmy Ly, Hua Luo, Ellie Hogan, Maria Eleni Fafouti and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Nuo Xu *Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Katherine M Rynard *Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0009-0006-7005-1817
Elizabeth RadleyDepartment of Biochemistry, University of Toronto, Toronto, ON, Canada.
Ai TianProgram in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
Maahil ArshadDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0009-0001-8979-3072
Chaoying LongDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Jimmy LyWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Hua LuoDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Ellie HoganKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Maria Eleni FafoutiKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Melanie DavieDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Fatima NaimiProgram in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
Yun LiDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-5849-5910
John A CalarcoDepartment of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-2197-7801
Brett TrostDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Julien MuffatDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Hyun O LeeDepartment of Biochemistry, University of Toronto, Toronto, ON, Canada.
Howard D LipshitzDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada. howard.lipshitz@utoronto.ca.ORCID http://orcid.org/0000-0002-7372-4419
Craig A SmibertDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada. c.smibert@utoronto.ca.ORCID http://orcid.org/0000-0001-6375-8669
Shreejoy J TripathyKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada. shreejoy.tripathy@utoronto.ca.ORCID http://orcid.org/0000-0002-1007-9061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA splicing shapes neuronal identity and disease risk, yet current maps lack the developmental resolution and depth to resolve this complexity. Here, we integrate deep long-read RNA sequencing and proteomics in induced pluripotent stem cell-derived cortical neurons to generate a high-resolution proteogenomic atlas of human neuron development. We identify 182,371 mRNA isoforms (over half previously unknown) and provide direct peptide evidence for the translation of hundreds of novel protein-coding sequences. Population genetics demonstrates that variants affecting novel exons and splice sites are under negative selection, underscoring the potential significance of these isoforms. During neuronal maturation, we observe that autism risk genes undergo dynamic isoform switching, including microexon inclusion and intron retention, that remodel key protein domains and regulatory regions. Furthermore, we uncover widespread, long-range coordination between alternative transcript processing events, including transcription start sites, exon splicing, and polyadenylation. Finally, our atlas enables variant reinterpretation in autism, highlighting the value of an isoform-centric view for interpreting pathogenic variation in neurodevelopment.

Indexed as

Cell DifferentiationNeuronsProteogenomicsAlternative SplicingAutistic DisorderExonsHumansInduced Pluripotent Stem CellsNeurodevelopmentNeurogenesisProtein IsoformsRNA, MessengerProtein IsoformsRNA, Messenger

Identifiers

PMID42680762
PMCPMC13534637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.